RxDoctor Payments Data

Karim Tadros, NP

Adult Health · Atlanta, GANPI 1639891450

Payments from drug & device makers

$520in general payments, 2019–2025

Across 20 payments — averaging $26.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Apellis Pharmaceuticals, Inc.$147
  • Daiichi Sankyo Inc.$125
  • Adaptive Biotechnologies Corporation$107
  • Takeda Pharmaceuticals U.S.A., Inc.$59
  • Puma Biotechnology, Inc.$32
  • Johnson & Johnson$26
  • plus $24 from 1 others

What the payments were for

  • Food & beverage$520100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$520 in reported general payments places this provider in the 55th percentile of 577 adult health providers in Georgia.

See all adult health providers in Georgia

Medicare billing

Part B allowed, 2024
$17,520
Medicare patients
104
Services billed
228

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Acyclovir11$330

Paid to pharmacies, not to this prescriber.

Other adult health in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →